Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 157

1.

Strategies to achieve adequate vitamin A intake for young children: options for Cameroon.

Vosti SA, Kagin J, Engle-Stone R, Luo H, Tarini A, Clermont A, Assiene JG, Nankap M, Brown KH.

Ann N Y Acad Sci. 2019 Dec 3. doi: 10.1111/nyas.14275. [Epub ahead of print]

PMID:
31797386
2.

PM2.5 induces vascular permeability increase through activating MAPK/ERK signaling pathway and ROS generation.

Long YM, Yang XZ, Yang QQ, Clermont AC, Yin YG, Liu GL, Hu LG, Liu Q, Zhou QF, Liu QS, Ma QC, Liu YC, Cai Y.

J Hazard Mater. 2019 Nov 10:121659. doi: 10.1016/j.jhazmat.2019.121659. [Epub ahead of print]

PMID:
31776080
3.

Retinal proteome associated with bradykinin-induced edema.

Murugesan N, Fickweiler W, Clermont AC, Zhou Q, Feener EP.

Exp Eye Res. 2019 Sep;186:107744. doi: 10.1016/j.exer.2019.107744. Epub 2019 Jul 24.

PMID:
31351056
4.

Retinol binding protein 3 is increased in the retina of patients with diabetes resistant to diabetic retinopathy.

Yokomizo H, Maeda Y, Park K, Clermont AC, Hernandez SL, Fickweiler W, Li Q, Wang CH, Paniagua SM, Simao F, Ishikado A, Sun B, Wu IH, Katagiri S, Pober DM, Tinsley LJ, Avery RL, Feener EP, Kern TS, Keenan HA, Aiello LP, Sun JK, King GL.

Sci Transl Med. 2019 Jul 3;11(499). pii: eaau6627. doi: 10.1126/scitranslmed.aau6627.

PMID:
31270273
5.

Pesticide residue profiles in bee bread and pollen samples and the survival of honeybee colonies-a case study from Luxembourg.

Beyer M, Lenouvel A, Guignard C, Eickermann M, Clermont A, Kraus F, Hoffmann L.

Environ Sci Pollut Res Int. 2018 Nov;25(32):32163-32177. doi: 10.1007/s11356-018-3187-4. Epub 2018 Sep 15.

PMID:
30220063
6.

Acceptability and Utilization of Three Nutritional Supplements during Pregnancy: Findings from a Longitudinal, Mixed-Methods Study in Niger.

Clermont A, Kodish SR, Matar Seck A, Salifou A, Rosen J, Grais RF, Isanaka S.

Nutrients. 2018 Aug 12;10(8). pii: E1073. doi: 10.3390/nu10081073.

7.

Determinants of dietary practices during pregnancy: A longitudinal qualitative study in Niger.

Rosen JG, Clermont A, Kodish SR, Matar Seck A, Salifou A, Grais RF, Isanaka S.

Matern Child Nutr. 2018 Oct;14(4):e12629. doi: 10.1111/mcn.12629. Epub 2018 Jun 28.

8.

Winter honey bee colony losses, Varroa destructor control strategies, and the role of weather conditions: Results from a survey among beekeepers.

Beyer M, Junk J, Eickermann M, Clermont A, Kraus F, Georges C, Reichart A, Hoffmann L.

Res Vet Sci. 2018 Jun;118:52-60. doi: 10.1016/j.rvsc.2018.01.012. Epub 2018 Feb 2.

PMID:
29421484
9.

Using community-based reporting of vital events to monitor child mortality: Lessons from rural Ghana.

Helleringer S, Arhinful D, Abuaku B, Humes M, Wilson E, Marsh A, Clermont A, Black RE, Bryce J, Amouzou A.

PLoS One. 2018 Jan 30;13(1):e0192034. doi: 10.1371/journal.pone.0192034. eCollection 2018.

10.

Effects of deworming on child and maternal health: a literature review and meta-analysis.

Thayer WM, Clermont A, Walker N.

BMC Public Health. 2017 Nov 7;17(Suppl 4):830. doi: 10.1186/s12889-017-4747-0. Review.

11.
12.

Nutrition Interventions in the Lives Saved Tool (LiST).

Clermont A, Walker N.

J Nutr. 2017 Nov;147(11):2132S-2140S. doi: 10.3945/jn.116.243766. Epub 2017 Sep 13. Review.

PMID:
28904118
13.

Estimating Lives Saved by Achieving Dietary Micronutrient Adequacy, with a Focus on Vitamin A Intervention Programs in Cameroon.

Engle-Stone R, Perkins A, Clermont A, Walker N, Haskell MJ, Vosti SA, Brown KH.

J Nutr. 2017 Nov;147(11):2194S-2203S. doi: 10.3945/jn.116.242271. Epub 2017 Sep 13. Review.

PMID:
28904117
14.

New Option in the Lives Saved Tool (LiST) Allows for the Conversion of Prevalence of Small-for-Gestational-Age and Preterm Births to Prevalence of Low Birth Weight.

Kozuki N, Katz J, Clermont A, Walker N; Child Health Epidemiology Reference Group SGA–Preterm Birth Working Group.

J Nutr. 2017 Nov;147(11):2141S-2146S. doi: 10.3945/jn.117.247767. Epub 2017 Sep 13. Review.

PMID:
28904115
15.

The Lives Saved Tool (LiST) as a Model for Prevention of Anemia in Women of Reproductive Age.

Heidkamp R, Guida R, Phillips E, Clermont A.

J Nutr. 2017 Nov;147(11):2156S-2162S. doi: 10.3945/jn.117.252429. Epub 2017 Sep 13. Review.

PMID:
28904114
16.

Modeling the Impact of Nutrition Interventions on Birth Outcomes in the Lives Saved Tool (LiST).

Heidkamp R, Clermont A, Phillips E.

J Nutr. 2017 Nov;147(11):2188S-2193S. doi: 10.3945/jn.116.243667. Epub 2017 Sep 13. Review.

PMID:
28904112
17.

Iris Malformation and Anterior Segment Dysgenesis in Mice and Humans With a Mutation in PI 3-Kinase.

Solheim MH, Clermont AC, Winnay JN, Hallstensen E, Molven A, Njølstad PR, Rødahl E, Kahn CR.

Invest Ophthalmol Vis Sci. 2017 Jun 1;58(7):3100-3106. doi: 10.1167/iovs.16-21347.

18.

Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.

Simão F, Ustunkaya T, Clermont AC, Feener EP.

Blood. 2017 Apr 20;129(16):2280-2290. doi: 10.1182/blood-2016-09-740670. Epub 2017 Jan 27.

19.

Evaluating anesthetic protocols for functional blood flow imaging in the rat eye.

Moult EM, Choi W, Boas DA, Baumann B, Clermont AC, Feener EP, Fujimoto JG.

J Biomed Opt. 2017 Jan 1;22(1):16005. doi: 10.1117/1.JBO.22.1.016005.

20.

Plasma Kallikrein Mediates Vascular Endothelial Growth Factor-Induced Retinal Dysfunction and Thickening.

Clermont A, Murugesan N, Zhou Q, Kita T, Robson PA, Rushbrooke LJ, Evans DM, Aiello LP, Feener EP.

Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2390-9. doi: 10.1167/iovs.15-18272.

21.

Health Aspects of Climate Change in Cities with Mediterranean Climate, and Local Adaptation Plans.

Paz S, Negev M, Clermont A, Green MS.

Int J Environ Res Public Health. 2016 Apr 21;13(4):438. doi: 10.3390/ijerph13040438.

22.

[Factitious diseases in oncology].

Reich M, Clermont A, Amela É, Kotecki N.

Bull Cancer. 2015 Dec;102(12):1036-45. doi: 10.1016/j.bulcan.2015.09.006. Epub 2015 Nov 18. Review. French.

PMID:
26597474
23.

Negatively charged silver nanoparticles cause retinal vascular permeability by activating plasma contact system and disrupting adherens junction.

Long YM, Zhao XC, Clermont AC, Zhou QF, Liu Q, Feener EP, Yan B, Jiang GB.

Nanotoxicology. 2016;10(4):501-11. doi: 10.3109/17435390.2015.1088589. Epub 2015 Sep 23.

24.

Impacts of Climate Change on Vector Borne Diseases in the Mediterranean Basin - Implications for Preparedness and Adaptation Policy.

Negev M, Paz S, Clermont A, Pri-Or NG, Shalom U, Yeger T, Green MS.

Int J Environ Res Public Health. 2015 Jun 15;12(6):6745-70. doi: 10.3390/ijerph120606745.

25.

Correlations between land covers and honey bee colony losses in a country with industrialized and rural regions.

Clermont A, Eickermann M, Kraus F, Hoffmann L, Beyer M.

Sci Total Environ. 2015 Nov 1;532:1-13. doi: 10.1016/j.scitotenv.2015.05.128. Epub 2015 Jun 5.

PMID:
26057621
26.

Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema.

Kita T, Clermont AC, Murugesan N, Zhou Q, Fujisawa K, Ishibashi T, Aiello LP, Feener EP.

Diabetes. 2015 Oct;64(10):3588-99. doi: 10.2337/db15-0317. Epub 2015 May 15.

27.

Modeling targeted inhibition of MEK and PI3 kinase in human pancreatic cancer.

Junttila MR, Devasthali V, Cheng JH, Castillo J, Metcalfe C, Clermont AC, Otter DD, Chan E, Bou-Reslan H, Cao T, Forrest W, Nannini MA, French D, Carano R, Merchant M, Hoeflich KP, Singh M.

Mol Cancer Ther. 2015 Jan;14(1):40-7. doi: 10.1158/1535-7163.MCT-14-0030. Epub 2014 Nov 5.

28.

Tumor shrinkage with lanreotide Autogel 120 mg as primary therapy in acromegaly: results of a prospective multicenter clinical trial.

Caron PJ, Bevan JS, Petersenn S, Flanagan D, Tabarin A, Prévost G, Maisonobe P, Clermont A; PRIMARYS Investigators.

J Clin Endocrinol Metab. 2014 Apr;99(4):1282-90. doi: 10.1210/jc.2013-3318. Epub 2013 Jan 1.

29.

Identification and analysis of in vivo VEGF downstream markers link VEGF pathway activity with efficacy of anti-VEGF therapies.

Brauer MJ, Zhuang G, Schmidt M, Yao J, Wu X, Kaminker JS, Jurinka SS, Kolumam G, Chung AS, Jubb A, Modrusan Z, Ozawa T, James CD, Phillips H, Haley B, Tam RN, Clermont AC, Cheng JH, Yang SX, Swain SM, Chen D, Scherer SJ, Koeppen H, Yeh RF, Yue P, Stephan JP, Hegde P, Ferrara N, Singh M, Bais C.

Clin Cancer Res. 2013 Jul 1;19(13):3681-92. doi: 10.1158/1078-0432.CCR-12-3635. Epub 2013 May 17.

30.

Intraocular hemorrhage causes retinal vascular dysfunction via plasma kallikrein.

Liu J, Clermont AC, Gao BB, Feener EP.

Invest Ophthalmol Vis Sci. 2013 Feb 7;54(2):1086-94. doi: 10.1167/iovs.12-10537.

31.

Measurement of pulsatile total blood flow in the human and rat retina with ultrahigh speed spectral/Fourier domain OCT.

Choi W, Baumann B, Liu JJ, Clermont AC, Feener EP, Duker JS, Fujimoto JG.

Biomed Opt Express. 2012 May 1;3(5):1047-61. doi: 10.1364/BOE.3.001047. Epub 2012 Apr 19.

32.

Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice.

Rask-Madsen C, Buonomo E, Li Q, Park K, Clermont AC, Yerokun O, Rekhter M, King GL.

Arterioscler Thromb Vasc Biol. 2012 May;32(5):1124-31. doi: 10.1161/ATVBAHA.111.239558. Epub 2012 Mar 15.

33.

Inflation in the number of eligibility criteria for industry-sponsored phase II cancer clinical trial: illustration over a 20-year period.

Clisant S, Clermont A, Adenis A, Penel N.

Contemp Clin Trials. 2012 May;33(3):459. doi: 10.1016/j.cct.2012.02.009. Epub 2012 Feb 16. No abstract available.

PMID:
22366776
34.

Plasma kallikrein mediates retinal vascular dysfunction and induces retinal thickening in diabetic rats.

Clermont A, Chilcote TJ, Kita T, Liu J, Riva P, Sinha S, Feener EP.

Diabetes. 2011 May;60(5):1590-8. doi: 10.2337/db10-1260. Epub 2011 Mar 28.

35.

Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein.

Liu J, Gao BB, Clermont AC, Blair P, Chilcote TJ, Sinha S, Flaumenhaft R, Feener EP.

Nat Med. 2011 Feb;17(2):206-10. doi: 10.1038/nm.2295. Epub 2011 Jan 23.

36.

Vitreous proteomics and diabetic retinopathy.

Walia S, Clermont AC, Gao BB, Aiello LP, Feener EP.

Semin Ophthalmol. 2010 Sep-Nov;25(5-6):289-94. doi: 10.3109/08820538.2010.518912. Review.

37.

Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models.

Singh M, Lima A, Molina R, Hamilton P, Clermont AC, Devasthali V, Thompson JD, Cheng JH, Bou Reslan H, Ho CC, Cao TC, Lee CV, Nannini MA, Fuh G, Carano RA, Koeppen H, Yu RX, Forrest WF, Plowman GD, Johnson L.

Nat Biotechnol. 2010 Jun;28(6):585-93. doi: 10.1038/nbt.1640. Epub 2010 May 23.

PMID:
20495549
38.

Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice.

Rask-Madsen C, Li Q, Freund B, Feather D, Abramov R, Wu IH, Chen K, Yamamoto-Hiraoka J, Goldenbogen J, Sotiropoulos KB, Clermont A, Geraldes P, Dall'Osso C, Wagers AJ, Huang PL, Rekhter M, Scalia R, Kahn CR, King GL.

Cell Metab. 2010 May 5;11(5):379-89. doi: 10.1016/j.cmet.2010.03.013.

39.

Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy.

Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A, Aiello LP, Kern TS, King GL.

Nat Med. 2009 Nov;15(11):1298-306. doi: 10.1038/nm.2052. Epub 2009 Nov 1.

40.

Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes.

Gao BB, Phipps JA, Bursell D, Clermont AC, Feener EP.

J Proteome Res. 2009 Dec;8(12):5541-9. doi: 10.1021/pr9006415.

41.

Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability.

Phipps JA, Clermont AC, Sinha S, Chilcote TJ, Bursell SE, Feener EP.

Hypertension. 2009 Feb;53(2):175-81. doi: 10.1161/HYPERTENSIONAHA.108.117663. Epub 2009 Jan 5.

42.

Studies with an orally bioavailable alpha V integrin antagonist in animal models of ocular vasculopathy: retinal neovascularization in mice and retinal vascular permeability in diabetic rats.

Santulli RJ, Kinney WA, Ghosh S, Decorte BL, Liu L, Tuman RW, Zhou Z, Huebert N, Bursell SE, Clermont AC, Grant MB, Shaw LC, Mousa SA, Galemmo RA Jr, Johnson DL, Maryanoff BE, Damiano BP.

J Pharmacol Exp Ther. 2008 Mar;324(3):894-901. Epub 2007 Dec 14.

PMID:
18083913
43.

Glypican 4, a membrane binding protein for bactericidal/permeability-increasing protein signaling pathways in retinal pigment epithelial cells.

Geraldes P, Yamagata M, Rook SL, Sassa Y, Ma RC, Clermont A, Gao B, Aiello LP, Feener EP, King GL.

Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5750-5.

PMID:
18055828
44.

Immunoglobulin receptor evolution in follicular lymphoma and a review of literature.

Seitz V, Stiege A, Mundlos S, Lenze D, Lammert H, Clermont A, Hirsch B, Von Der Wall E, Müller H, Kirsch A, Diaz-Espada F, Uharek L, Anagnostopoulos I, Stein H, Hummel M.

Leuk Lymphoma. 2007 Oct;48(10):2063-7. Review. No abstract available.

PMID:
17917975
45.

Retinal blood flow in diabetes.

Clermont AC, Bursell SE.

Microcirculation. 2007 Jan;14(1):49-61. Review.

PMID:
17365661
46.

Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation.

Gao BB, Clermont A, Rook S, Fonda SJ, Srinivasan VJ, Wojtkowski M, Fujimoto JG, Avery RL, Arrigg PG, Bursell SE, Aiello LP, Feener EP.

Nat Med. 2007 Feb;13(2):181-8. Epub 2007 Jan 28.

PMID:
17259996
47.

Noninvasive volumetric imaging and morphometry of the rodent retina with high-speed, ultrahigh-resolution optical coherence tomography.

Srinivasan VJ, Ko TH, Wojtkowski M, Carvalho M, Clermont A, Bursell SE, Song QH, Lem J, Duker JS, Schuman JS, Fujimoto JG.

Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5522-8.

48.

Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.

Ohshiro Y, Ma RC, Yasuda Y, Hiraoka-Yamamoto J, Clermont AC, Isshiki K, Yagi K, Arikawa E, Kern TS, King GL.

Diabetes. 2006 Nov;55(11):3112-20.

49.

Bactericidal/permeability-increasing protein's signaling pathways and its retinal trophic and anti-angiogenic effects.

Yamagata M, Rook SL, Sassa Y, Ma RC, Geraldes P, Goddard L, Clermont A, Gao B, Salti H, Gundel R, White M, Feener EP, Aiello LP, King GL.

FASEB J. 2006 Oct;20(12):2058-67.

PMID:
17012258
50.

In vivo monitoring of pancreatic beta-cells in a transgenic mouse model.

Smith SJ, Zhang H, Clermont AO, Powers AC, Kaufman DB, Purchio AF, West DB.

Mol Imaging. 2006 Apr-Jun;5(2):65-75.

PMID:
16954020

Supplemental Content

Loading ...
Support Center